Thanks to COVID-19 and numerous other factors, the adoption of digital health technologies used by patients in the home has skyrocketed. Accenture reported in 2021, for example, that remote patient monitoring technology adoption tripled among patients. Whether it is streaming video telehealth appointments with a provider, a remote patient monitoring platform, or a prescribed digital therapeutic to manage a chronic condition, the emphasis must be on the patient and caregiver
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Syapse and Pierian Partner to Power Precision Oncology
What You Should Know: - Syapse, a real-world evidence company is teaming up with Pierian®, a provider of advanced clinical genomics technology on a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. - The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and precision medicine services that provide the most relevant
Read More
BestLife Holdings Raises $50M+ Portfolio Expansion with Cenegenics
What You Should Know: - BestLife Holdings, a portfolio of personalized preventative healthcare and age management solutions, announces its formation with a combined equity round of over $50M. Notable investors have partnered with BestLife including PrimeTime Partners’ founders, Abby Levy, the co-founder of Thrive Global with Arianna Huffington, and Alan Patricof, founder of Greycroft Partners and Apax Partners, who also joined the board as an observer. Consumer and digital health
Read More
Imagene Raises $21.5M to Expand Image-Based Biomarker Detection for Precision Medicine
What You Should Know: - Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced it raised $21.5 million, comprising $3M in seed funding led by Blumberg Capital and an $18.5M Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura. - The use of AI-based molecular testing in cancer diagnostics is revolutionizing patient care by offering a new level of
Read More
Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions
What You Should Know: - Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care. - Through this research agreement, VUNO will establish a collaboration with Mayo Clinic to develop innovative AI and machine learning solutions for more precise diagnosis, prognosis and treatment stratification in cancer. - This collaborative agreement combines
Read More
Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials
What You Should Know: - Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC
Read More
VivoSense Raises $25M for Wearable Sensor Biomarkers to Advance Clinical Trials
What You Should Know: - VivoSense, an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data raises $25 Million in Series A funding. - The financing will accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. VivoSense will also use this financing to expand and refine its informatics platform for data analysis from wearable and connected technologies to deliver validated digital
Read More
Why Mainstream Precision Medicine Hinges on Healthcare HPC Storage
The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down. In 2020, estimates reported that healthcare data comprised a staggering 30% of the world’s total data volume; projections for 2025 bump that number up to 36%, a growth rate outpacing every other industry. This is promising news for precision medicine, the data-driven healthcare initiative that promotes the right treatment for the right patient at the right time. Precision (or personalized)
Read More
Tempus Launches Pathology-Driven AI Platform
What You Should Know: - Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide. - With access to over 50 petabytes of de-identified multimodal data, Tempus is developing AI models with the aim to identify patients who would
Read More
EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment in Children
What You Should Know: - EarliTec Dx, a digital health company developing novel diagnostic and therapeutic products for children with Autism Spectrum Disorder (ASD) and early childhood vulnerabilities, today announced a $19.5 million financing led by Bernie Marcus, with participation from the Georgia Research Alliance (GRA). - This round of financing will be used to support filing with the U.S. Food and Drug Administration (FDA) for 510K clearance, as well as commercialization of the
Read More
